Similarly, inhibiting POLRMT with 2′-C-methyladenosine (2-CM), a potent inhibitor of HCV RNA-dependent RNA polymerase that also targets POLRMT, reduced mitochondrial gene expression in conjunction with AML tumor growth in a concentration-dependent manner [113]. The gene discussed is POLRMT; the disease is acute myeloid leukemia.